An observational study in Acute Coronary Syndromes, Heart Failure and Pulmonary Edema, sponsored by University of Sao Paulo General Hospital. Status unknown at 6 sites in Brazil. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2018-10-24.
Sponsored by University of Sao Paulo General Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Acute Coronary Syndrome with a site in Brazil — 4 open to participants now, 5 under way, 1 of them phase 3. Acute Coronary Syndrome · Brazil.
Among the 52 studies in Acute Coronary Syndrome with a site in Brazil, this one is one of 4 that started in 2015, is one of 9 observational ones, and was the 36th registered.
1,491 studies on the registry are indexed under Acute Coronary Syndrome; 272 are open to participants now.
Browse Acute Coronary Syndrome studies →4 of the 52 studies in Acute Coronary Syndrome with a site in Brazil are open now. Recruiting first, the newest first:
University of Sao Paulo · Sites in Brazil
Ages 18+
University of Sao Paulo · Sites in Brazil
Ages 18+
Hospital Israelita Albert Einstein · Sites in Brazil
University of the State of Santa Catarina · Sites in Brazil
Ages 35–80
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 195 Acute Coronary Syndrome studies recruiting now, 144 (74%) set no upper age limit and 19 (10%) stop at 75 or younger; 15 take children under 18; 15 take healthy volunteers.
This study: 18 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 5 · Phase 3 17 · Phase 4 9
First in 2000; this study’s year is marked. 4 started in 2015.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,650 is above the median of 500 across 590 observational studies indexed under Acute Coronary Syndrome.
Median enrollment 1,801 across the 43 interventional studies, 600 across the 9 observational. Of the 38 that completed or were terminated, 14 (37%) have results posted.
This tab as a report to print or save as PDF → With an account.
20 of 52 have an industry lead sponsor. The 10 most frequent:
University of Sao Paulo General Hospital is the lead sponsor of 612 studies on the registry; 99 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
University of Sao Paulo General Hospital has 8 studies filed under Acute Coronary Syndrome — fewer than ten, so there is no comparison to draw.
1 of the studies in Acute Coronary Syndrome with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07734831University of the State of Santa CatarinaTELEREHAB-BR: Cardiovascular Rehabilitation Models Trial | 2027-08 |
Add it to your calendar (.ics) → With an account.
Among the 52 studies in Acute Coronary Syndrome with a site in Brazil, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Critical patients in emergency room are seriously situations that need quickly diagnosis and treatment. Different predictors of prognosis can be related with mortality and morbidity in-hospital and in long-term. In Brazil, this kind of registry is not available. The aim of the study is analysis and report data about critical patients in Emergency Departments over all country, showing demographic, clinical and prognosis data about that in Brazil.
This will be a prospective and multicentric data-bank registry. Initially, all patients with acute coronary syndromes (ACS), acute decompensated heart failure (ADHF), warfarin intoxication, acute pulmonary edema, acute aortic dissection, chest pain, pulmonary embolism and syncope will be included. There will be not exclusion criteria. The inclusion criteria will be followed by definition of each illness described in recent guidelines. Investigators estimated annually over than 500 cases with ACS/chest pain, 300 cases of ADHF, 200 cases of aortic dissection, 200 of pulmonary embolism, 200 cases of warfarin intoxication, 100 cases of syncope and 150 of acute pulmonary edema. Clinical data, electrocardiographic and echocardiographic findings, laboratory results and prognosis will be related. Routine of treatment will be defined by each center. The analysis includes minimum, medium and maximum values. Variables will be adjusted according with each diagnosis and all data will be included using the REDCap digital data entry. Probabilities will be determined by logistic regression and will be considered significate when p \< 0.005. Prospectively, investigators will use the Cox model to calculate associations.
emergency unit patients
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-There will be not exclusion criteria.
No intervention related
Other: no intervention
No intervention related
Other: no intervention
No intervention related
Other: no intervention
No intervention related
Other: no intervention
No intervention related
Other: no intervention
No intervention related
Other: no intervention
No intervention related
Other: no intervention
No intervention related
Other: no intervention
No intervention related
mortality
Time frame: 6 months
mortality
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
Started May 2015 (actual). Primary completion is estimated for Jan 2019, 44 months after the start.
Of 243 non-industry observational studies under Acute Coronary Syndrome, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 71. This study's planned 44 months is above that.
Counting every sponsor, half of 277 studies reached it within 35 months; a quarter within 18 and three quarters within 68.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Sao Paulo General Hospital →